Zenas Biopharma, Inc
ZBIO
Loading quote...
Financials
| 52Week High | 26.25 | 52Week Low | 5.83 |
| Beta | 0.79 | Current Ratio Annual | 6.21 |
| Current Ratio Quarterly | 5.23 | Market Cap | 671.44M |
| Price To Book | 2.80 | Quick Ratio Annual | 6.12 |
| Quick Ratio Quarterly | 5.13 | Return On Assets TTM | -50.56 |
| Return On Equity TTM | -59.21 | Return On Investment TTM | -59.21 |
| Revenue Per Share TTM | 0.36 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 66 | 5 | 2 | 2 | 1 | 0 | 31.70M | $254.70M |
| Mar 31, 2025 | 68(+3%) | 12(+140%) | 9(+350%) | 14(+600%) | 20(+1900%) | 19(+%) | 32.49M(+2%) | $252.11M(-1%) |
| Jun 30, 2025 | 72(+6%) | 8(-33%) | 5(-44%) | 32(+129%) | 13(-35%) | 16(-16%) | 33.93M(+4%) | $323.73M(+28%) |